Compare EA & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EA | ZTS |
|---|---|---|
| Founded | 1982 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4B | 54.8B |
| IPO Year | 2006 | 2012 |
| Metric | EA | ZTS |
|---|---|---|
| Price | $199.66 | $127.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 11 |
| Target Price | ★ $188.20 | $156.20 |
| AVG Volume (30 Days) | 2.9M | ★ 4.3M |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | 0.38% | ★ 1.64% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | 1.68 | ★ 6.02 |
| Revenue | $7,463,000,000.00 | ★ $9,467,000,000.00 |
| Revenue This Year | $11.35 | $5.79 |
| Revenue Next Year | $3.63 | $5.16 |
| P/E Ratio | $119.08 | ★ $21.42 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $128.87 | $115.25 |
| 52 Week High | $204.89 | $177.00 |
| Indicator | EA | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 39.75 | 53.52 |
| Support Level | $199.12 | $124.50 |
| Resistance Level | $203.35 | $132.49 |
| Average True Range (ATR) | 2.02 | 4.08 |
| MACD | -0.16 | 0.20 |
| Stochastic Oscillator | 40.90 | 61.84 |
Electronic Arts is one of the largest global developers and publishers of video games. Its most important franchises are the Madden NFL and FC soccer games, which it releases annually. In 2024, it also relaunched its American college football game. Other major franchises include Apex Legends, Battlefield, and The Sims. Typically, about three quarters of the firm's sales are from in-game spending, with the remainder coming from initial game sales.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.